Based on the case (Angioleiomyoma, 60/F, popliteal fossa subcutaneous swelling), here are the most likely viva questions with sharp, exam-quality answers:
MD Pathology Viva — Case 3 (Angioleiomyoma)
1877/26 H1 | 60/F | Popliteal fossa subcutaneous swelling
SECTION 1: OPENING / SLIDE DESCRIPTION
Q1. How will you describe this slide at the beginning?
"The section shows a well-circumscribed, encapsulated soft tissue lesion composed of interlacing fascicles of spindle cells with blunt-ended, cigar-shaped nuclei and abundant deeply eosinophilic fibrillar cytoplasm, consistent with smooth muscle differentiation. Prominent thick-walled blood vessels are distributed throughout the tumor. No nuclear atypia, mitotic figures, or necrosis are identified. Features are consistent with Angioleiomyoma (Vascular Leiomyoma)."
Q2. What is the single most important diagnostic clue on this H&E slide?
The blunt-ended (cigar-shaped) nucleus with abundant deeply eosinophilic fibrillar cytoplasm - these are the hallmarks of smooth muscle differentiation. Combined with the prominent vascular component, the diagnosis is Angioleiomyoma.
SECTION 2: DEFINITION AND CLASSIFICATION
Q3. What is an Angioleiomyoma?
Angioleiomyoma (also called vascular leiomyoma or angiomyoma) is a benign, well-circumscribed, encapsulated soft tissue tumor arising from the smooth muscle of vessel walls (tunica media). It is the most common leiomyoma of soft tissue. It is classified under benign smooth muscle tumors of soft tissue.
Q4. What are the three histological subtypes of Angioleiomyoma?
| Subtype | Features |
|---|
| Solid (Capillary) | Compact smooth muscle bundles, few small vessels, sparse stroma |
| Venous | Thick-walled muscular vessels, smooth muscle bundles between them (most common) |
| Cavernous | Large, dilated thin-walled channels with sparse intervening muscle |
The venous type is the most common overall; the solid type is more common in the uterus.
Q5. What is the origin of this tumor?
It arises from the smooth muscle of vessel walls (tunica media of small arteries and veins), which explains why the tumor contains prominent thick-walled vessels throughout. The pericytes and vascular smooth muscle cells are the cells of origin.
SECTION 3: CLINICAL FEATURES
Q6. What is the classic clinical presentation of Angioleiomyoma?
- Age: 40-60 years (middle-aged adults)
- Sex: More common in women (F:M = 2:1)
- Site: Lower extremity > upper extremity > head and neck
- Lower leg (calf/ankle) and popliteal fossa are the MOST COMMON sites
- Presentation: Slowly growing, painful subcutaneous nodule (pain is characteristic - due to presence of nerve fibers within the tumor reacting to cold/pressure)
- Size: Usually small (1-2 cm), well-demarcated
Q7. Why is Angioleiomyoma painful?
Pain is a characteristic feature. It is due to:
- Nerve fibers within the tumor capsule and stroma that are stimulated by pressure or cold
- Ischemia due to contraction of smooth muscle cells around vessels
- The venous type (most common) tends to be more painful than the solid or cavernous types
Q8. This patient is 60 years old female with popliteal fossa swelling - how does it fit the classic profile?
Perfectly classical:
- Female, age 60 - peak age-sex group
- Popliteal fossa (lower extremity) - most common anatomical site
- Subcutaneous location - characteristic
- Likely presented with pain and slowly growing swelling
SECTION 4: HISTOPATHOLOGY (DEEP DIVE)
Q9. What are the histological features of Angioleiomyoma?
- Encapsulation: Well-defined fibrous capsule (partial or complete)
- Spindle cells: Arranged in interlacing fascicles and whorling bundles
- Nuclear morphology: Blunt-ended, cigar-shaped, vesicular nuclei with finely granular chromatin - key smooth muscle feature
- Cytoplasm: Abundant, deeply eosinophilic, fibrillar; perinuclear vacuoles may be seen (especially in uterine type)
- Vascular component: Numerous thick-walled vessels (arterioles/venules) with smooth muscle walls blending imperceptibly into surrounding tumor cells - this is the DEFINING feature separating it from ordinary leiomyoma
- Stroma: Collagenous to focally myxoid; scattered lymphocytes and plasma cells
- NO mitoses, NO atypia, NO necrosis - benign
Q10. What is the key histological difference between a Leiomyoma and an Angioleiomyoma?
| Feature | Leiomyoma | Angioleiomyoma |
|---|
| Vascular component | Sparse/minimal | Prominent thick-walled vessels throughout |
| Cell arrangement | Interlacing fascicles | Same + cells blend with vessel walls |
| Origin | Smooth muscle (non-vascular) | Smooth muscle of vessel wall (vascular) |
| Common site | Uterus, skin | Subcutaneous, lower extremity |
| Encapsulation | Variable | Usually well-encapsulated |
The vessels are an integral structural component of the tumor in angioleiomyoma (not just feeding vessels), and the smooth muscle cells merge with and are continuous with the vessel walls.
Q11. What do the vessels look like in the venous type?
In the venous type (as seen here):
- Thick-walled muscular vessels with well-developed tunica media
- The smooth muscle of the vessel wall transitions directly into the tumor stroma - there is NO clear boundary between vessel wall and tumor cells
- Lumens may be irregular, slit-like, or round
- Vessels are distributed throughout the entire tumor, not just at the periphery
Q12. What is the significance of the inflammatory infiltrate seen in this slide?
A scattered chronic inflammatory infiltrate (lymphocytes and plasma cells) within the stroma is a characteristic but non-specific feature. It is seen in angioleiomyoma and is thought to represent a reactive response to the tumor. It does NOT indicate malignancy. However, it must be distinguished from:
- Inflammatory Myofibroblastic Tumor (where inflammation is more prominent and ALK+ )
- Inflammatory leiomyosarcoma (where cytological atypia is present)
SECTION 5: IMMUNOHISTOCHEMISTRY
Q13. What IHC markers will be positive in Angioleiomyoma?
| Marker | Result | Significance |
|---|
| SMA (α-smooth muscle actin) | Strongly positive | Confirms smooth muscle differentiation |
| Desmin | Positive | Smooth muscle marker |
| h-Caldesmon | Positive | Specific for smooth muscle (differentiates from myofibroblasts) |
| Vimentin | Positive | Non-specific |
| S100 | Negative | Excludes schwannoma/nerve sheath tumor |
| CD34 | Negative/focal | Excludes solitary fibrous tumor |
| CD117 (c-Kit) | Negative | Excludes GIST |
| DOG-1 | Negative | Excludes GIST |
| Ki-67 (MIB-1) | Very low (<1%) | Confirms benign nature |
Memory tip: SMA + Desmin + h-Caldesmon = smooth muscle tumor. S100 negative = NOT neural.
Q14. How do you differentiate Angioleiomyoma from Schwannoma on IHC?
| Feature | Angioleiomyoma | Schwannoma |
|---|
| S100 | Negative | Strongly positive |
| SMA | Strongly positive | Negative |
| Desmin | Positive | Negative |
| SOX10 | Negative | Positive |
| H&E nuclear shape | Blunt/cigar-shaped | Wavy/buckled |
| Antoni A/B areas | Absent | Present |
| Verocay bodies | Absent | Present |
| Encapsulation | Yes | Yes (complete) |
SECTION 6: DIFFERENTIAL DIAGNOSIS
Q15. What are the differential diagnoses for this case and how do you exclude each?
1. Schwannoma:
- Has Antoni A (cellular, Verocay bodies) and Antoni B (myxoid, loose) areas
- Nuclei are wavy/buckled, NOT blunt-ended
- S100 strongly positive; SMA negative
- EXCLUDED by nuclear morphology and IHC
2. Nodular Fasciitis:
- Reactive, NOT neoplastic; not encapsulated
- "Tissue culture" pattern - loosely arranged cells
- Rich myxoid stroma with extravasated red cells ("torn tissue" appearance)
- Usually presents acutely in young adults (<30 years), short history (weeks)
- Self-limiting
- EXCLUDED by encapsulation, age, and smooth muscle morphology
3. Fibromatosis (Desmoid tumor):
- Infiltrative, NOT encapsulated
- Bland fibroblasts/myofibroblasts in dense collagen
- No significant vascularity
- Nuclear beta-catenin positive
- SMA weakly positive, Desmin negative
- EXCLUDED by encapsulation and SMA/Desmin staining pattern
4. GIST (Gastrointestinal Stromal Tumor):
- Rare in subcutaneous tissue
- CD117+ and DOG-1+
- Associated with KIT/PDGFRA mutations
- EXCLUDED by CD117 and DOG-1 negativity + subcutaneous location
5. Leiomyosarcoma:
- Marked nuclear atypia (>3-fold variation in nuclear size)
- Mitotic activity >10/10 HPF; atypical mitoses
- Necrosis (coagulative)
- Poor encapsulation, infiltrative borders
- EXCLUDED in this case - no atypia, no mitoses, no necrosis
SECTION 7: SPECIAL STAINS
Q16. What special stains can be used to confirm smooth muscle differentiation?
- Masson's Trichrome: Smooth muscle stains red/pink; collagen stains blue/green - helps quantify the smooth muscle component
- PAS (Periodic Acid Schiff): Highlights basement membrane around smooth muscle cells
- van Gieson's stain: Smooth muscle = yellow; collagen = red
However, IHC (SMA, Desmin) has largely replaced special stains in modern practice.
SECTION 8: PATHOGENESIS AND MOLECULAR
Q17. What is the pathogenesis of Angioleiomyoma?
- Arises from the smooth muscle cells of the tunica media of small blood vessels (arteries and veins) in subcutaneous tissue
- Not associated with specific genetic mutations (unlike uterine leiomyomas which have MED12 mutations)
- No hormonal dependence demonstrated in soft tissue angioleiomyomas (unlike uterine type)
- The pain may be related to encapsulated nerve fibers within the tumor (demonstrated on S100 and neurofilament staining)
Q18. Are there any molecular/genetic associations?
- Uterine leiomyomas: MED12 mutations (70%), HMGA2 rearrangements
- Soft tissue angioleiomyoma: No consistent molecular abnormality identified
- This is a benign, non-aggressive tumor with no malignant potential
- Unlike uterine leiomyomas, estrogen/progesterone receptor expression in soft tissue angioleiomyoma is variable and less consistent
SECTION 9: PROGNOSIS AND TREATMENT
Q19. What is the treatment and prognosis?
- Treatment: Simple surgical excision with clear margins
- Prognosis: Excellent - benign behavior
- Recurrence: Rare after complete excision (<5%)
- Malignant transformation: Extremely rare (essentially does not occur in subcutaneous angioleiomyoma)
- Post-excision, the patient is cured; no adjuvant therapy required
Q20. Can a leiomyoma undergo malignant transformation to leiomyosarcoma?
This is a controversial and important question:
- In soft tissue: Malignant transformation of a benign leiomyoma/angioleiomyoma to leiomyosarcoma is extremely rare and not well-documented
- In uterus: Leiomyosarcoma arises de novo, NOT from a pre-existing leiomyoma (this is the current consensus)
- The criteria for malignancy in smooth muscle tumors:
- Mitoses >10/10 HPF (uterus) or >5/10 HPF (soft tissue)
- Nuclear atypia
- Coagulative necrosis
- Infiltrative margins
SECTION 10: COMPARISON TABLE (The Examiner's Favorite)
Q21. Compare Angioleiomyoma, Leiomyosarcoma, and Schwannoma in a table:
| Feature | Angioleiomyoma | Leiomyosarcoma | Schwannoma |
|---|
| Age/Sex | 40-60, F>M | Adults | Any age |
| Site | Subcutaneous LL | Retroperitoneum, uterus, soft tissue | Peripheral nerves |
| Encapsulation | Yes | No (infiltrative) | Yes (complete) |
| Nuclear shape | Blunt/cigar | Blunt + pleomorphic | Wavy/buckled |
| Atypia | None | Moderate-marked | None |
| Mitoses | Absent/rare | >5-10/10 HPF | Rare |
| Necrosis | Absent | Present | Absent |
| Vessels | Prominent, thick-walled | Variable | Variable |
| Antoni A/B | Absent | Absent | Present |
| Verocay bodies | Absent | Absent | Present |
| SMA | ++ | ++ | - |
| S100 | - | - | ++ |
| Desmin | ++ | ++ | - |
| CD117 | - | - | - |
| Behavior | Benign | Malignant | Benign |
| Treatment | Excision | Wide excision ± chemo/RT | Excision |
QUICK MEMORY POINTS FOR TOMORROW
"60F + Popliteal fossa + Painful subcutaneous nodule = Think Angioleiomyoma"
- Blunt cigar nuclei + eosinophilic fibrillar cytoplasm = SMOOTH MUSCLE
- Thick-walled vessels throughout = ANGIO- component
- Encapsulated = BENIGN
- SMA ++ / S100 -- = NOT a nerve sheath tumor
- No mitoses, no atypia, no necrosis = BENIGN behavior
- Simple excision = CURED
Source: Robbins & Cotran Pathologic Basis of Disease, WHO Classification of Soft Tissue Tumors (5th Ed.), Enzinger & Weiss Soft Tissue Tumors.
Best of luck for tomorrow! 🙏